|
|
|
1 | (16) |
|
|
| Part I Evaluations and Decisions |
|
|
2 Evidence Based Medicine: Quality of Evidence and Evaluation Systems |
|
|
17 | (18) |
|
|
|
|
|
3 Decision Analytic Techniques and Other Decision Processes |
|
|
35 | (12) |
|
|
|
|
|
4 Decision Making: The Surgeon's Perspective |
|
|
47 | (12) |
|
|
|
5 Decision Making: The Patient's Perspective |
|
|
59 | (16) |
|
|
|
|
| Part II Lung |
|
|
6 Indications for Pretreatment Pathologic Mediastinal Staging in Non-small Cell Lung Cancer |
|
|
75 | (10) |
|
|
|
|
|
7 Preoperative Smoking Cessation for Lung Resection Patients |
|
|
85 | (14) |
|
|
|
|
|
8 High Tech Exercise Testing in Assessing Candidates for Lung Resection |
|
|
99 | (10) |
|
|
|
|
|
9 Management of Perioperative Anticoagulation in Lung Resection |
|
|
109 | (16) |
|
|
|
|
|
10 Perioperative Arrhythmia Prophylaxis for Major Lung Resection |
|
|
125 | (12) |
|
|
|
|
|
11 VATS Versus Open Lobectomy for Stage I or II NSCLC |
|
|
137 | (16) |
|
|
|
|
|
|
|
12 Robotic-Assisted Thoracoscopic Surgery (RATS) Versus Video-Assisted Thoracoscopic Surgery (VATS) Lobectomy for Stage I or II Non-small Cell Lung Cancer |
|
|
153 | (12) |
|
|
|
|
|
13 Lobectomy After Induction Therapy for NSCLC in the Presence of Persistent N2 Disease |
|
|
165 | (12) |
|
|
|
14 Pneumonectomy After Induction Therapy for Non-small Cell Lung Cancer |
|
|
177 | (10) |
|
|
|
|
|
15 Resection Versus SBRT for Stage I Non-small Cell Lung Cancer in Patients with Good Pulmonary Function |
|
|
187 | (12) |
|
|
|
16 Digital Drainage Systems After Major Lung Resection |
|
|
199 | (8) |
|
|
|
17 Management of Persistent Post-operative Alveolar Air Leak |
|
|
207 | (22) |
|
|
|
|
|
18 Surveillance After Resection of Stage I Non Small Cell Lung Cancer |
|
|
229 | (10) |
|
|
|
19 Support Therapy for Lung Failure: The Utility of Device Therapy |
|
|
239 | (12) |
|
|
|
|
|
20 Extracorporeal Support for Lung Grafts Prior to Transplantation |
|
|
251 | (6) |
|
|
|
|
|
21 Pulmonary Metastasectomy |
|
|
257 | (14) |
|
|
| Part III Esophagus |
|
|
22 Optimal Therapy for Barrett High Grade Dysplasia |
|
|
271 | (16) |
|
|
|
|
|
23 Preoperative Chemo Versus Chemoradiotherapy for Regionally Advanced Esophageal Adenocarcinoma |
|
|
287 | (14) |
|
|
|
|
|
24 The Role of Surgery in the Management of Regionally Advanced Esophageal Squamous Cell Cancer |
|
|
301 | (10) |
|
|
|
|
|
25 Optimal Surgical Approach to Esophagectomy for Distal Esophageal Adenocarcinoma |
|
|
311 | (14) |
|
|
|
26 Regional Extent of Lymphadenectomy for Esophageal Cancer |
|
|
325 | (12) |
|
|
|
|
|
|
|
27 Optimal Lymph Node Dissection in Esophageal Cancer |
|
|
337 | (14) |
|
|
|
|
|
28 Salvage Esophagectomy for Persistent or Recurrent Disease After Definitive Chemoradiotherapy |
|
|
351 | (14) |
|
|
|
|
|
29 Gastric Emptying Procedure After Esophagectomy |
|
|
365 | (12) |
|
|
|
|
|
30 Postoperative Adjuvant Therapy After Resection of Regionally Advanced Esophageal Cancer |
|
|
377 | (10) |
|
|
|
|
|
31 Prophylactic Antireflux Surgery in Lung Transplantation |
|
|
387 | (12) |
|
|
|
|
|
|
|
32 Surgical Versus Endoscopic Management for Esophageal Perforations |
|
|
399 | (14) |
|
|
|
|
|
33 Stents for Esophageal Anastomotic Leak |
|
|
413 | (10) |
|
|
|
|
|
34 Management of Small Esophageal GIST Tumors |
|
|
423 | (6) |
|
|
|
|
|
35 Surgery for Minimally Symptomatic Pulsion Diverticula of the Thoracic Esophagus |
|
|
429 | (6) |
|
|
|
|
|
36 Partial Versus Total Fundoplication for GERD in Patients with Normal Esophageal Motility |
|
|
435 | (14) |
|
|
|
|
| Part IV Diaphragm |
|
|
|
|
449 | (12) |
|
Francoise Le Pimpec-Barthes |
|
|
38 Minimally Invasive Versus Open Repair of Giant Paraesophageal Hernia |
|
|
461 | (12) |
|
|
|
|
|
39 Synthetic Reinforcement of Diaphragm Closure for Large Hiatal Hernia Repair |
|
|
473 | (26) |
|
|
|
40 Diaphragmatic Plication for Eventration |
|
|
499 | (12) |
|
|
|
|
|
41 Management of Minimally Symptomatic Recurrent Hiatal Hernia |
|
|
511 | (20) |
|
|
|
|
| Part V Airway |
|
|
42 Stenting for Benign Airway Obstruction |
|
|
531 | (34) |
|
|
|
43 Bioengineered Tissues for Tracheal Reconstruction |
|
|
565 | (12) |
|
|
|
|
|
44 Percutaneous Versus Standard Tracheostomy in the Critically Ill Adult |
|
|
577 | (12) |
|
|
|
|
|
45 Carinal Resection for Non Small Cell Lung Cancer |
|
|
589 | (12) |
|
|
|
|
| Part VI Pleura and Pleural Spaces |
|
|
46 Management of Persistent Postoperative Air Leaks |
|
|
601 | (12) |
|
|
|
47 Fibrinolytics for Managing Pleural Empyema |
|
|
613 | (10) |
|
|
|
|
|
48 VATS Versus Open Management of Pleural Empyema |
|
|
623 | (12) |
|
|
|
|
|
|
|
49 Optimal Management of Symptomatic Malignant Pleural Effusion |
|
|
635 | (12) |
|
|
|
|
|
50 Pleurectomy Versus Radical Pleuropneumonectomy for Malignant Pleural Mesothelioma |
|
|
647 | (12) |
|
|
|
|
|
51 Surgical and Medical Therapy for Malignant Pleural Mesothelioma |
|
|
659 | (18) |
|
|
| Part VII Mediastinum |
|
|
52 Extended Versus Standard Thymectomy for Myasthenia Gravis |
|
|
677 | (12) |
|
|
|
|
|
|
|
53 Optimal Approach for Resection of Encapsulated Thymoma: Open Versus VATS |
|
|
689 | (10) |
|
|
|
|
|
54 Robotic Versus VATS Thymectomy for Encapsulated Thymoma |
|
|
699 | (10) |
|
|
|
|
|
55 Video Mediastinoscopy Versus Standard Mediastinoscopy |
|
|
709 | (8) |
|
|
|
|
|
56 Debulking for Extensive Thymoma |
|
|
717 | (8) |
|
|
|
|
|
57 Surgery for Palmar Hyperhidrosis: Patient Selection and Extent of Surgery |
|
|
725 | (22) |
|
|
|
|
| Part VIII Chest Wall |
|
|
58 Synthetic Versus Biologic Reconstruction of Bony Chest Wall Defects |
|
|
747 | (8) |
|
|
|
59 Management of Flail Chest |
|
|
755 | (12) |
|
|
|
|
|
60 Management of Pectus Deformities in Adults |
|
|
767 | (8) |
|
|
|
|
|
|
|
|
| Index |
|
775 | |
Biežāk uzdotie jautājumi par e-grāmatām